Internal Medicine, Hematology & Oncology · Little Rock, AR
NPI
1619959525
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
8901 Carti Way
Little Rock, AR, 72205
Phone (501) 219-8777
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.2M
222,865 services
Medicare patients, 2024
1,427
Average age 75
Drug cost, 2024
$5.7M
3,211 prescriptions
Company payments, 2024
$42.13
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diane D Wilder was code J9271 (injection, pembrolizumab, 1 mg), 22,800 times for 33 patients. In total Diane D Wilder billed 222,865 services in 222 codes, and Medicare paid $4.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 22,800 | 33 | $43.48 | $991K |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 12,780 | 18 | $0.39 | $4,961 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 12,750 | 13 | $0.27 | $3,406 |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 11,700 | 13 | $0.06 | $645 |
| J9025 Injection, azacitidine, 1 mg | Office | 10,300 | 12 | $0.30 | $3,051 |
| J9299 Injection, nivolumab, 1 mg | Office | 8,700 | 13 | $24.67 | $215K |
| J0185 Injection, aprepitant, 1 mg | Office | 8,190 | 23 | $1.34 | $11K |
| J0897 Injection, denosumab, 1 mg | Office | 6,300 | 39 | $19.61 | $124K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 6,300 | 56 | $15.83 | $100K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 6,275 | 56 | $6.30 | $40K |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,861 | 13 | $0.08 | $465 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 5,400 | 12 | $0.11 | $593 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 5,135 | 113 | $0.09 | $464 |
| J0461 Injection, atropine sulfate, 0.01 mg | Office | 4,775 | 18 | $0.06 | $306 |
| Q5114 Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg | Office | 2,640 | 14 | $42.85 | $113K |
By year: 2022 $3.2M for 305,007 services; 2023 $3.8M for 234,527 services; 2024 $4.2M for 222,865 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 2,615 | 927 | $8.62 | $23K |
| 85025 Blood Count | 1,751 | 591 | $7.55 | $13K |
| 80053 Clinical Chemistry | 1,545 | 549 | $10.28 | $16K |
| 82378 Clinical Chemistry | 807 | 397 | $18.46 | $15K |
| 86300 Immunoassay | 680 | 349 | $20.29 | $14K |
| 82728 Clinical Chemistry | 215 | 132 | $13.09 | $2,813 |
| 83540 Clinical Chemistry | 212 | 130 | $6.21 | $1,316 |
| 83550 Clinical Chemistry | 212 | 130 | $8.39 | $1,779 |
| 83735 Clinical Chemistry | 208 | 63 | $6.48 | $1,347 |
| 82306 Clinical Chemistry | 193 | 146 | $28.88 | $5,574 |
Medicare prescription drug claims, 2024
In 2024, the drug Diane D Wilder prescribed most often to Medicare patients was Anastrozole, with 849 prescriptions and refills. In total Diane D Wilder wrote 3,211 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 849 | 1,663 | 224 | $13K |
| Tamoxifen Citrate Generic | 204 | 378 | 51 | $4,053 |
| Letrozole Generic | 166 | 323 | 55 | $2,948 |
| Exemestane Generic | 147 | 212 | 32 | $10K |
| Eliquis Apixaban | 104 | 117 | 13 | $66K |
| Fulvestrant Generic | 102 | 102 | 14 | $64K |
| Prochlorperazine Maleate Generic | 95 | 95 | 51 | $1,375 |
| Olanzapine Generic | 82 | 91 | 42 | $1,060 |
| Neulasta Onpro Pegfilgrastim | 80 | 80 | 30 | $591K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 69 | 129 | 23 | $1,711 |
| Trazimera Trastuzumab-Qyyp | 66 | 66 | 11 | $290K |
| Prednisone Generic | 57 | 61 | 34 | $276 |
| Doxycycline Monohydrate Generic | 55 | 55 | 44 | $681 |
| Ibrance Palbociclib | 52 | 52 | Under 11 | $828K |
| Tagrisso Osimertinib Mesylate | 48 | 48 | Under 11 | $800K |
Brand drugs: - claims; generic drugs: 2,525 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Diane D Wilder $42.13 ($42.13 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $25.95.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.